Background. Amyotrophic Lateral Sclerosis (ALS) is a devastating disease involving motor
neuron degeneration. The few drugs approved for treatment have at most a marginal benefit …

Abstract Background. Amyotrophic Lateral Sclerosis (ALS) is a devastating disease
involving motor neuron degeneration. The few drugs approved for treatment have at most a …

ALSUntangled reviews alternative and off-label treatments for people living with
amyotrophic lateral sclerosis (PALS). Here we review insulin, which has at least one …

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder with limited
therapeutic options. Clinical trials of several drugs shown to be effective in the superoxide …

Background Several metabolic derangements associated with diabetes mellitus type 2 (DM)
have been associated with a better outcome in amyotrophic lateral sclerosis (ALS), including …

Our objectives were to analyse carbohydrate metabolism in a series of ALS patients and to
examine potential association with parameters of lipid metabolism and clinical features …

Abnormal glucose and insulin metabolism have often been reported in patients with
amyotrophic lateral sclerosis. Recently, we have demonstrated reduced insulin sensitivity in …

Background: Amyotrophic Lateral Sclerosis (ALS) is a degenerative disorder which affects
the motor neurons. Growing evidence suggests that ALS may impact the metabolic system …

Importance Although prior studies have suggested a role of cardiometabolic health on
pathogenesis of amyotrophic lateral sclerosis (ALS), the association with diabetes mellitus …

Background Amyotrophic lateral sclerosis (ALS) is an incurable motor neuron degenerative
disease which onset and course may be affected by concurrent diabetes mellitus (DM). We …